Clinical Trial Update: The Purpose of the Study is to Evaluate the Effect of Ruxolitinib Cream on Itch in Participants With Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of Ruxolitinib Cream on itch in participants with atopic dermatitis completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Ruxolitinib Cream (ruxolitinib)

Snippet

Sponsor: Incyte Corporation | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2023-10-31